Alexandar Kolevzon, MD

Dr. Alex Kolevzon is a child and adolescent psychiatrist and Professor of Psychiatry and Pediatrics at the Icahn School of Medicine at Mount Sinai. He serves as the Director of Child and Adolescent Psychiatry for the Mount Sinai Health System and the Clinical Director of the Seaver Autism Center for Research and Treatment at Mount Sinai. His research interests pertain to understanding the neurobiology of autism and related neurodevelopmental disorders, biomarker discovery, and developing novel therapeutics. Most recently, his group has focused on studying specific genetic forms of autism, including Phelan-McDermid syndrome, FOXP1 syndrome, and ADNP syndrome, in order to explore targets for pharmacological intervention. Dr. Kolevzon leads the Experimental Therapeutics Program at the Seaver Autism Center which conducts studies that range from small pilot trials to multi-centered pivotal FDA studies. He also leads a national rare disease clinical research network dedicated to clinical trial readiness and studying the natural history of Phelan-McDermid syndrome. He is a frequently invited speaker regionally, nationally, and internationally and is also extremely committed to medical student and residency education as an active teacher, mentor, and clinical supervisor.